Capital International Investors Neurocrine Biosciences Inc Transaction History

Capital International Investors

$504 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $3.56 Million - $4.71 Million	-47,027 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $764,347 - $1 Million	-10,550 Reduced 18.32%	47,027 $4.41 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $31 Million - $41.4 Million	-389,442 Reduced 87.12%	57,577 $4.9 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $57.7 Million - $66.3 Million	-669,144 Reduced 59.95%	447,019 $42.9 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $40.8 Million - $46.7 Million	-456,163 Reduced 29.01%	1,116,163 $109 Million
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $161 Million - $220 Million	-1,840,323 Reduced 53.93%	1,572,326 $153 Million
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $75 Million - $93.5 Million	-862,827 Reduced 20.18%	3,412,649 $327 Million
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $175 Million - $246 Million	-1,820,920 Reduced 29.87%	4,275,476 $411 Million
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $6.49 Million - $9.95 Million	76,293 Added 1.27%	6,096,396 $744 Million
Q1 2020 May 15, 2020	BUY	$75.11 - $113.76 $14.1 Million - $21.4 Million	187,960 Added 3.22%	6,020,103 $521 Million
Q4 2019 Feb 18, 2020	BUY	$86.8 - $118.57 $144,695 - $197,656	1,667 Added 0.03%	5,832,143 $627 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $16.8 Million - $20.3 Million	200,122 Added 3.55%	5,830,476 $525 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $87 Million - $110 Million	1,203,754 Added 27.19%	5,630,354 $475 Million
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $62.5 Million - $82.5 Million	901,600 Added 25.58%	4,426,600 $390 Million
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $223 Million - $406 Million	3,267,000 Added 1266.28%	3,525,000 $252 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $25.5 Million - $32.5 Million	258,000 New	258,000 $31.7 Million

Others Institutions Holding NBIX

# of Institutions

642

Shares Held

94.3M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.74 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.23 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$631 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$316 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$229 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account